Articles published by GlobeNewswire
The Inaugural Beijing Art & Technology Week to Debut at 798 Art District
November 13, 2025
From 798 Art District
Via GlobeNewswire
Via GlobeNewswire
Tickers
SUNS
Directed share issuance to NVIDIA completed – a change in the total number of Nokia shares
November 13, 2025
From Nokia Oyj
Via GlobeNewswire
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
Via GlobeNewswire
Tickers
IPSC
Bread Financial Provides Performance Update for October 2025
November 13, 2025
Via GlobeNewswire
Tickers
BFH
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
Via GlobeNewswire
Tickers
ABUS
FitLife Brands Announces Third Quarter 2025 Results
November 13, 2025
From FitLife Brands, Inc.
Via GlobeNewswire
Tickers
FTLF
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
November 13, 2025
Via GlobeNewswire
Tickers
XLO
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 13, 2025
Via GlobeNewswire
Tickers
SGMT
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
Via GlobeNewswire
Tickers
CLRB
Via GlobeNewswire
Tickers
IPSC
Applied Therapeutics Reports Third Quarter 2025 Financial Results
November 13, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers
APLT
Newton Golf Company Reports Third Quarter 2025 Results
November 13, 2025
From Newton Golf Company
Via GlobeNewswire
Tickers
NWTG
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
November 13, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
Tickers
TRAW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
